Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.

Yosipovitch G et al.

NCBI PubMed Central · Papers · License: Open Access

philosophy of mind

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 380622
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.